SCHEMBL25569229

SCHEMBL25569229

c1ccc2c(-c3ccc(Nc4ccc(-c5cc6ccccc6c6ccccc56)cc4)cc3)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
ALDH1A1 P00352 5/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
TSHR P16473 2/20 0.44
HIF1A Q16665 2/20 0.44
MAPK1 P28482 1/20 0.44
CASP1 P29466 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA9 Q16790 3/20 0.44
CYP11B1 P15538 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
MPI P34949 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26021707 0.95 ALDH1A1 (0.47) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL24947193 0.93 CA12 (0.42) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL31146385 0.93 CA12 (0.42) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL31146352 0.93 CA12 (0.42) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL29926129 0.91 CYP11B1 (0.49) ALDH1A1HPGDHSD17B10TSHRHIF1A
SCHEMBL20462477 0.91 CYP11B1 (0.49) ALDH1A1HPGDHSD17B10TSHRHIF1A
SCHEMBL23277121 0.90 ALDH1A1 (0.43) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL29637423 0.90 ALDH1A1 (0.43) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL25088292 0.90 HPRT1 (0.50) HDAC8HDAC6ALDH1A1HPGDHSD17B10
SCHEMBL10136271 0.89 HDAC8 (0.54) HDAC8HDAC6ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 US disclosed
WO-2023096209-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2023-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 HDAC8 4041/4885HDAC6 3346/4885ALDH1A1 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.